OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
21
Results
Show all
Save search
Copy query
Show results for
Unknown
(21)
Publication Date
Release Date
2025
(4)
2022
(4)
2024
(3)
2021
(3)
2015
(3)
2020
(2)
2023
(1)
2016
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Stability of SARS-CoV-2 Spike G614 Variant Surpasses That of the D614 Variant after Cold Storage.
Not available
S-EPMC8546686
|
biostudies-literature
Cite
Culture-Based Virus Isolation To Evaluate Potential Infectivity of Clinical Specimens Tested for COVID-19.
Not available
S-EPMC7383522
|
biostudies-literature
Cite
SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East.
Not available
S-EPMC7473175
|
biostudies-literature
Cite
Quantifying Neutralizing Antibodies in Patients with COVID-19 by a Two-Variable Generalized Additive Model.
Not available
S-EPMC8809379
|
biostudies-literature
Cite
Immunogenicity of second booster-dose COVID-19 mRNA vaccine among older adults in Taiwan.
Not available
S-EPMC12688691
|
biostudies-literature
Cite
Comprehensive Introduction to ASIAN-HF Registry.
Not available
S-EPMC12426648
|
biostudies-literature
Cite
Ultrahigh-energy gamma-ray emission associated with black hole-jet systems.
Not available
S-EPMC12746838
|
biostudies-literature
Cite
Prediction of human population responses to toxic compounds by a collaborative competition.
Not available
S-EPMC4568441
|
biostudies-literature
Cite
Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023.
Not available
S-EPMC11487098
|
biostudies-literature
Cite
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial.
Not available
S-EPMC9384272
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets